Related Experiment Videos
Signal averaging in patients with coronary artery disease: how helpful is it?
M Shenasa1, T Fetsch, A Martínez-Rubio
1Department of Cardiology and Angiology, Hospital of the University of Münster, Germany.
Insights
Ventricular late potentials detected by signal-averaged ECG in myocardial infarction survivors identify high-risk patients for arrhythmias. Absence of these potentials indicates a low risk, guiding intervention decisions.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Survivors of acute myocardial infarction (MI) are at risk for malignant ventricular arrhythmias.
- Ventricular late potentials (VLPs) on signal-averaged ECG (SAECG) suggest slow conduction, a substrate for arrhythmias.
- Risk stratification is crucial for post-MI patients to prevent sudden cardiac death (SCD).
Purpose of the Study:
- To evaluate the role of VLPs detected by SAECG in identifying post-MI patients at risk for ventricular tachycardia (VT) and SCD.
- To assess the predictive value of VLPs, alone and in combination with other parameters, for arrhythmia risk.
Main Methods:
- High-resolution signal-averaged ECG (SAECG) was used to detect ventricular late potentials (VLPs).
- Analysis was performed in the time and/or frequency domain.
- VLPs were correlated with clinical variables like left ventricular ejection fraction and ventricular ectopy.
Main Results:
- Presence of VLPs in post-MI patients indicates areas of slow conduction and potential substrate for malignant ventricular arrhythmias.
- VLPs are a useful index for risk stratification of VT and SCD, especially when combined with left ventricular ejection fraction and complex ventricular ectopy.
- Absence of VLPs has a high negative predictive value, indicating a low risk for VT or SCD, even with complex ectopy.
Conclusions:
- VLPs on SAECG are valuable for identifying high-risk post-MI patients for malignant ventricular tachyarrhythmias.
- The negative predictive value of VLPs is high, suggesting interventions may not be needed if VLPs are absent.
- SAECG's ability to predict propensity to ventricular fibrillation is limited, and its use in predicting response to pharmacologic interventions requires further study.
Abstract:
In patients who have survived acute myocardial infarction, the presence of ventricular late potentials using the high resolution signal-averaged ECG indicates areas of slow conduction and delayed activation that may potentially serve as a substrate for malignant ventricular arrhythmias. Although detection of late potentials is technique specific, signal-averaged analysis in the time or frequency domain may be a useful index for risk stratification with regard to ventricular tachycardia or sudden cardiac death. The sensitivity and specificity of late potentials for this purpose may be enhanced by combination with other variables, such as left ventricular ejection fraction and presence of complex ventricular ectopy. Therefore, the presence of ventricular late potentials in postmyocardial infarction patients, particularly in those patients with impaired left ventricular function, identifies those patients who are at high risk of malignant ventricular tachyarrhythmias. However, the strategies for prevention of serious arrhythmia complications during follow-up need to be established. The negative predictive value of late potentials is very high. Thus, the absence of late potentials indicates a low propensity to sustained ventricular tachycardia or sudden death, even in the presence of complex ventricular ectopy. Interventions may therefore not be necessary or should even be avoided. The incidence of late potentials in patients with spontaneous or induced ventricular fibrillation is lower and, if present, less pronounced than in those with sustained monomorphic ventricular tachycardia. This presumably is due to a lower degree of conduction delay, which serves as a substrate for reentry. Therefore, the ability of the signal-averaged ECG to predict a propensity to ventricular fibrillation is limited. Despite these limitations, the signal-averaged ECG may be used as a risk predictor in evaluation of patients after myocardial infarction. Unfortunately, at least as far as time domain analysis is concerned, it cannot be used as an efficacy predictor for response to pharmacologic interventions. Further studies will determine whether other modes of signal-averaged analysis can predict the response to drugs.